McKesson Corp Q1 2025 10-Q Filed

TL;DR

McKesson's Q1 2025 10-Q is in, showing latest financials. Check it for debt and equity details.

AI Summary

McKesson Corporation filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the first fiscal quarter of 2025. Key financial data and disclosures related to its business segments, debt, and equity are presented.

Why It Matters

This filing provides investors and analysts with the latest financial health and strategic direction of McKesson, a major player in the healthcare distribution industry.

Risk Assessment

Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.

Key Numbers

• 2024-06-30 — Reporting Period End (End of the fiscal quarter for which financial results are reported.)
• 2024-08-07 — Filing Date (Date the 10-Q was officially submitted to the SEC.)
• 2025-03-31 — Fiscal Year End (McKesson's fiscal year concludes on this date.)

Key Players & Entities

• MCKESSON CORP (company) — Filer
• 20240630 (date) — Reporting Period End Date
• 20240807 (date) — Filing Date
• 6555 STATE HIGHWAY 161 (address) — Business Address
• IRVING, TX 75039 (address) — Business Address

FAQ

Key Financial Figures

• $0.01 — nge on which registered) Common stock, $0.01 par value MCK New York Stock Exchange

Filing Documents

• mck-20240630.htm (10-Q) — 1344KB
• mck_exhibit31xamendedcoi.htm (EX-3.1) — 75KB
• mck_ex312xcertificateofame.htm (EX-3.1 2) — 7KB
• mck_exhibit311x630202410-q.htm (EX-31.1) — 10KB
• mck_exhibit312x630202410-q.htm (EX-31.2) — 10KB
• mck_exhibit32x630202410-q.htm (EX-32) — 9KB
• mck-20240630_g1.jpg (GRAPHIC) — 11KB
• 0000927653-24-000098.txt ( ) — 8062KB
• mck-20240630.xsd (EX-101.SCH) — 46KB
• mck-20240630_cal.xml (EX-101.CAL) — 68KB
• mck-20240630_def.xml (EX-101.DEF) — 309KB
• mck-20240630_lab.xml (EX-101.LAB) — 652KB
• mck-20240630_pre.xml (EX-101.PRE) — 491KB
• mck-20240630_htm.xml (XML) — 1215KB

—FINANCIAL INFORMATION

PART I—FINANCIAL INFORMATION 1 Condensed Consolidated Financial Statements Condensed Consolidated Statements of Operations for the three months ended June 30, 2024 and 2023 3 Condensed Consolidated Statements of Comprehensive Income for the three months ended June 30, 2024 and 2023 4 Condensed Consolidated Balance Sheets as of June 30, 2024 and March 31, 2024 5 Condensed Consolidated Statements of Stockholders' Deficit for the three months ended June 30, 2024 and 2023 6 Condensed Consolidated Statements of Cash Flows for the three months ended June 30, 2024 and 2023 7 Financial Notes 8 Note 1 - Significant Accounting Policies 8 Note 2 - Restructuring, Impairment, and Related Charges, Net 9 Note 3 - Income Taxes 11 Note 4 - Earnings Per Common Share 12 Note 5 - Goodwill and Intangible Assets, Net 13 Note 6 - Debt and Financing Activities 14 Note 7 - Hedging Activities 16 Note 8 - Fair Value Measurements 19 Note 9 - Commitments and Contingent Liabilities 21 Note 1 0 - Stockholders' Deficit 24 Note 1 1 - Segments of Business 26 2 Management's Discussion and Analysis of Financial Condition and Results of Operations 29 3 Quantitative and Qualitative Disclosures About Market Risk 41 4 Controls and Procedures 41

—OTHER INFORMATION

PART II—OTHER INFORMATION 1 Legal Proceedings 42 1A Risk Factors 42 2 Unregistered Sales of Equity Securities and Use of Proceeds 42 3 Defaults Upon Senior Securities 43 4 Mine Safety Disclosures 43 5 Other Information 43 6 Exhibits 44

Signatures

Signatures 45 2 Table of Contents McKESSON CORPORATION

—FINANCIAL INFORMATION

PART I—FINANCIAL INFORMATION

Condensed Consolidated Financial Statements

Item 1. Condensed Consolidated Financial Statements. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In millions, except per share amounts) (Unaudited) Three Months Ended June 30, 2024 2023 Revenues $ 79,283 $ 74,483 Cost of sales ( 76,131 ) ( 71,461 ) Gross profit 3,152 3,022 Selling, distribution, general, and administrative expenses ( 2,001 ) ( 1,870 ) Claims and litigation charges, net ( 112 ) — Restructuring, impairment, and related charges, net ( 10 ) ( 52 ) Total operating expenses ( 2,123 ) ( 1,922 ) Operating income 1,029 1,100 Other income, net 130 38 Interest expense ( 75 ) ( 47 ) Income before income taxes 1,084 1,091 Income tax expense ( 124 ) ( 94 ) Net income 960 997 Net income attributable to noncontrolling interests ( 45 ) ( 39 ) Net income attributable to McKesson Corporation $ 915 $ 958 Earnings per common share attributable to McKesson Corporation Diluted $ 7.00 $ 7.02 Basic $ 7.04 $ 7.07 Weighted-average common shares outstanding Diluted 130.7 136.6 Basic 129.8 135.5 See Financial Notes 3 Table of Contents McKESSON CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (In millions) (Unaudited) Three Months Ended June 30, 2024 2023 Net income $ 960 $ 997 Other comprehensive income (loss), net of tax Foreign currency translation adjustments ( 31 ) 52 Unrealized gains on cash flow and other hedges — 7 Changes in retirement-related benefit plans ( 1 ) ( 2 ) Other comprehensive income (loss), net of tax ( 32 ) 57 Comprehensive income 928 1,054 Comprehensive income attributable to noncontrolling interests ( 45 ) ( 39 ) Comprehensive income attributable to McKesson Corporation $ 883 $ 1,015 See Financial Notes 4 Table of Contents McKESSON CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In millions, except per share amounts) (Unaudited) June 30, 2024 March 31, 2024 ASSETS Current assets Cash and cash equivalents $ 2,302 $ 4,583 Receivables, ne

View Full Filing

View this 10-Q filing on SEC EDGAR